SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is attracting market attention as investors monitor the company's strategic pivot toward theme park expansion and streaming profitability, while community discussions remain divided between long-term optimism for its core franchises and concerns over high debt levels and content performance. Sentiment is further fueled by speculation surrounding potential M&A activity and the transition to new leadership, creating a high-tension environment for traders navigating the stock's recent volatility.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently in the spotlight as investors closely monitor upcoming CMS Medicare Advantage rate announcements, which are viewed as a potential catalyst for stabilizing the stock. The community remains divided, with some highlighting the company's defensive value and AI-driven cost-efficiency efforts, while others express concern over regulatory pressures and ongoing volatility in the broader healthcare sector.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillos is seeing intense investor focus as the stock hits fresh lows, with the community actively debating whether the brand's cult following and new location openings in markets like Georgia justify an undervalued entry point or signal a deeper decline. Sentiment remains polarized between long-term bulls highlighting institutional buying and high demand at new sites, and frustrated shareholders concerned about leadership turnover and persistent margin pressures.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing heightened investor activity as the market weighs its major $250 billion U.S. connectivity investment pledge against concerns over competitive churn and legacy service declines. The community remains divided, with some traders targeting short-term technical breakouts or covered call income, while others debate the long-term viability of the telecom giant's fiber and satellite infrastructure strategy.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors digest persistent acquisition rumors involving major tech players and SpaceX, with community members actively debating the strategic value of the company's spectrum and existing partnerships. Long-term shareholders remain focused on a potential bidding war, while others monitor for official news to confirm whether the company's assets will be integrated into the satellite infrastructure of Amazon or SpaceX.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is surging as investors cheer a massive AI server backlog and a bullish revenue outlook that signals the company is a primary beneficiary of the industry's shift toward accelerated infrastructure. The stock is currently the focus of heavy institutional accumulation and active debate, with traders weighing the strong fundamental momentum against its rapid recent price expansion.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

The Shiba Inu community is actively debating the coin's future, with supporters highlighting recent regulatory clarity and potential supply-side mechanisms while critics continue to label the project as a speculative gamble. Sentiment remains highly polarized as investors weigh rumors of token burns against persistent concerns regarding long-term price performance and the broader volatility of the meme coin sector.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply and small market cap, with the community actively speculating on the potential for a major price breakout if volume increases. Traders are fixated on these tokenomics, often comparing the asset to historical cycles and discussing the prospect of significant gains if it gains traction on major exchanges.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is facing significant market volatility as investors weigh the mixed interim phase two results for its cystic fibrosis candidate, ARCT-032, against its potential long-term platform value. While the community is actively debating the significance of the observed mucus clearance signals versus the lack of immediate FEV1 improvement, many are closely monitoring institutional accumulation and potential acquisition interest in the company's proprietary LUNAR delivery technology.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussions center on the company's improved cash flow position and its upcoming participation in the J.P. Morgan Healthcare Conference, which investors hope will serve as a catalyst for potential strategic partnerships or acquisition interest. Simultaneously, shareholders remain focused on the legal uncertainty surrounding the pending Supreme Court decision on patent infringement and the impact of generic competition on the company's core U.S. market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

8,437 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Nilsine Partners LLC

Nilsine Partners LLC purchased a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 11.2% during the 4th quarter, according to its most recent filing with...

Wealth Enhancement Advisory Services LLC Boosts Stake in Neurocrine Biosciences, Inc. $NBIX

Wealth Enhancement Advisory Services LLC grew its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure...

SG Americas Securities LLC Buys 119,339 Shares of Neurocrine Biosciences, Inc. $NBIX

SG Americas Securities LLC increased its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 785.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 134,530 shares of the compan...

Nordea Investment Management AB Increases Stake in Neurocrine Biosciences, Inc. $NBIX

Nordea Investment Management AB boosted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 81.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 27,202 shares of the company's stock after acquiring an additional 12,195 shares...

Assenagon Asset Management S.A. Has $11.35 Million Stock Position in Neurocrine Biosciences, Inc. $NBIX

Assenagon Asset Management S.A. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 70.4% in the fourth quarter, according to the company in its most recent...

Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings

Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings Neurocrine Biosciences Presents First Expert Consensus Recommendations for...

CIBC Private Wealth Group LLC Grows Stock Position in Neurocrine Biosciences, Inc. $NBIX

CIBC Private Wealth Group LLC boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 17,250.0% during the third quarter, according to the company in its most recent...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 47.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,510 shares of the company's st...

Neurocrine Biosciences Maps 2026 Execution, Data-Rich 2027; Ingrezza Guides $2.7B $2.8B

Neurocrine Biosciences (NASDAQ:NBIX) executives used a conference discussion to frame 2026 as a year of execution ahead of what they described as a data-rich 2027 across multiple mid- and late-stage...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.